Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Capital Employed (2016 - 2025)

Lisata Therapeutics' Return on Capital Employed history spans 12 years, with the latest figure at 1.09% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 37.0% year-over-year to 1.09%; the TTM value through Dec 2025 reached 1.09%, down 37.0%, while the annual FY2025 figure was 0.78%, 21.0% down from the prior year.
  • Return on Capital Employed reached 1.09% in Q4 2025 per LSTA's latest filing, down from 1.06% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.4% in Q2 2023 to a low of 1.09% in Q4 2025.
  • Average Return on Capital Employed over 3 years is 0.69%, with a median of 0.62% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: dropped -5bps in 2024, then plummeted -40bps in 2025.
  • A 3-year view of Return on Capital Employed shows it stood at 0.52% in 2023, then crashed by -40bps to 0.72% in 2024, then tumbled by -51bps to 1.09% in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Return on Capital Employed are 1.09% (Q4 2025), 1.06% (Q3 2025), and 0.92% (Q2 2025).